Clinical Trial Update: Estimation of the Effective Dose (ED) 95 of Intrathecal Hyperbaric Prilocaine 2% for Scheduled Cesarean Delivery. [Phase 2]

View source ↗

Summary

Phase 2 trial update estimating the effective dose of intrathecal hyperbaric prilocaine 2% for scheduled cesarean delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Delivery Anesthesia
• Pregnancy Complications During Labor

Drugs mentioned

• prilocaine 2% (intrathecal hyperbaric) (prilocaine)

Snippet

Sponsor: Centre Hospitalier Universitaire Saint Pierre | Conditions: Pregnant Women | Phase 2 | Status: COMPLETED